Table 1 Characteristics of patients on SABA over-use, on PRT with high OCS exposure, and on PRT
SABA over-use (23.9 per 100,000) | PRT with high OCS exposure (101.2 per 100,000) | PRT (4786.5 per 100,000) | ||||
|---|---|---|---|---|---|---|
Sex (%) 95% CI | ||||||
Female | 29.5 | 18.2–44.2 | 50.0 | 42.9–57.1 | 55.9 | 54.9–56.9 |
Male | 70.5 | 55.8–81.8 | 50.0 | 42.9–57.1 | 44.1 | 43.1–45.1 |
Age, med P25–P75 | 61.0 | 50.8–73.5 | 69.0 | 57.3–78.8 | 64.0 | 47.0–76.0 |
Age (%) 95% CI | ||||||
15:44 | 11.4 | 5.0–24.0 | 8.1 | 4.9–12.9 | 28.8 | 27.9–29.8 |
45:64 | 45.5 | 31.7–59.9 | 30.1 | 24.0–37.0 | 21.8 | 20.9–22.6 |
> 64 | 43.2 | 29.7–57.8 | 61.8 | 54.7–68.5 | 49.4 | 48.3–50.4 |
Maintenance-to-total prescribed (%) 95% CI | ||||||
No controller prescribed | 15.9 | 7.9–29.4 | – | – | ||
> 0 to 20% | 25.0 | 14.6–39.4 | 2.7 | 1.2–6.1 | 0.3 | 0.2–0.4 |
≥ 20 to < 50% | 31.8 | 20.0–46.6 | 35.5 | 29.0–42.6 | 3.3 | 2.9–3.7 |
≥ 50 to < 70% | 20.5 | 11.1–34.5 | 28.5 | 22.5–35.4 | 8.2 | 7.6–8.8 |
≥ 70 to < 90% | 6.8 | 2.3–18.2 | 28.0 | 22.0–34.8 | 16.3 | 15.5–17.1 |
≥ 90 to 100% | 0.0 | 0.0–8.0 | 5.4 | 2.9–9.6 | 72.0 | 71.0–72.9 |
Primary adherence to controller medication (%) 95% CI | ||||||
0% | 10.8 | 4.3–24.7 | 3.8 | 1.8–7.6 | 6.9 | 6.4–7.4 |
> 0 to 20% | 5.4 | 1.5–1.8 | 5.4 | 2.9–9.6 | 5.2 | 4.8–5.7 |
> 20 to 50% | 13.5 | 5.9–27.9 | 31.7 | 25.4–38.7 | 28.2 | 27.3–29.1 |
> 50 to 70% | 13.5 | 5.9–27.9 | 23.1 | 17.6–29.7 | 18.1 | 17.2–18.9 |
> 70 to 90% | 35.1 | 21.8–51.2 | 21.0 | 15.7–27.4 | 19.4 | 18.6–20.2 |
> 90 to 100% | 21.6 | 11.4–37.2 | 15.1 | 10.6–20.9 | 22.3 | 21.4–23.1 |